Business & Finance14 January 2025, 2:12 pm 1 minute
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news.
Article TagsTopics of Interest: Business & FinanceType: Reuters BestSectors: Business & FinanceRegions: AmericasWin Types: SpeedStory Types: Exclusive / ScoopMedia Types: TextCustomer Impact: Important Regional Story
Last Updated:December 10, 2024, 18:03 ISTWith healthcare costs soaring, a solid health insurance plan is more than just a safety netCustomers need to understand...
Himachal Pradesh To Boost Green Energy And e-Vehicle Infrastructure: The Himachal Pradesh government on Tuesday signed a Memorandum of Understanding (MoU) with two companies...
Getty ImagesCoffee drinkers may soon see their morning treat get more expensive, as the price of coffee on international commodity markets has hit its...
The market's strong performance reflects the impact of stabilising macroeconomic indicators and expectations of further monetary easing.
The Pakistan Stock Exchange's (PSX) benchmark KSE-100...